ICOS and neoplasm: Dual blockade of ICOS with anti-CTLA-4 has been effective in eliciting anti-tumor responses in ICOS knockout mice that were unresponsive to anti-CTLA-4 monotherapy (Fu et al., 2011; Fan et al., 2014).